Mark Wininger

Purification and Characterization of Oligomeric Envelope Glycoprotein from a Primary R5 Subtype B Human Immunodeficiency Virus

Indresh K. Srivastava, Leonidas Stamatatos, Harold Legg et al. · Journal of Virology · 2002 · 102 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +14

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies

Zania Stamataki, Stephen Coates, Matthew J. Evans et al. · Vaccine · 2007 · 86 citations

Life Sciences, Immunology, Infectious Diseases +12

Cationic microparticles are a potent delivery system for a HCV DNA vaccine

Derek T. O’Hagan, Manmohan Singh, Christine Dong et al. · Vaccine · 2004 · 75 citations

Pharmacy, Infectious Diseases, Pharmaceutics +16

Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates

Jens M. Heile, Y L Fong, Domenico Rosa et al. · Journal of Virology · 2000 · 73 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

Induction of Broad CD4⁺and CD8⁺T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5

Yinling Lin, Taewoo Kwon, John Polo et al. · Journal of Virology · 2008 · 52 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17